NCT02612740View on ClinicalTrials.gov

Deproteinized Bovine Bone in Alveolar Bone Critical Size Defect (>2cm) Secondary to Cyst Removal

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

October 31, 2016

Conditions

Maxillary Cyst

Interventions

BIOLOGICAL

Deproteinized bovine bone

cyst removal followed by heterologous bone grafting

DEVICE

granules of deproteinized bovine bone (Bio-Oss)

Sponsors

Collaborators (1)

Geistlich Pharma AG

All Listed Sponsors

collaborator

Geistlich Pharma AG

INDUSTRY

lead

University of Padova, School of Dental Medicine

OTHER

NCT02612740 - Deproteinized Bovine Bone in Alveolar Bone Critical Size Defect (>2cm) Secondary to Cyst Removal | Biotech Hunter | Biotech Hunter